These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34756074)

  • 61. Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy.
    Moreno MP; Casane D; López L; Cristina J
    Virol J; 2006 Oct; 3():87. PubMed ID: 17062150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fitness-associated substitutions following failure of direct-acting antivirals assessed by deep sequencing of full-length hepatitis C virus genomes.
    Fourati S; Rodriguez C; Soulier A; Donati F; Hamadat S; Poiteau L; Demontant V; Brillet R; Ahnou N; Gricourt G; Chevaliez S; Ahmed-Belkacem A; Pawlotsky JM
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1583-1591. PubMed ID: 32886807
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells.
    Maekawa S; Enomoto N; Sakamoto N; Kurosaki M; Ueda E; Kohashi T; Watanabe H; Chen CH; Yamashiro T; Tanabe Y; Kanazawa N; Nakagawa M; Sato C; Watanabe M
    J Viral Hepat; 2004 Sep; 11(5):394-403. PubMed ID: 15357644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B.
    Warter L; Cohen L; Benureau Y; Chavez D; Yang Y; Bodola F; Lemon SM; Traboni C; Lanford RE; Martin A
    PLoS One; 2009; 4(2):e4419. PubMed ID: 19204793
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.
    Veillon P; Payan C; Le Guillou-Guillemette H; Gaudy C; Lunel F
    World J Gastroenterol; 2007 Feb; 13(8):1195-203. PubMed ID: 17451199
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes.
    Moradpour D; Evans MJ; Gosert R; Yuan Z; Blum HE; Goff SP; Lindenbach BD; Rice CM
    J Virol; 2004 Jul; 78(14):7400-9. PubMed ID: 15220413
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase.
    Hong Z; Cameron CE; Walker MP; Castro C; Yao N; Lau JY; Zhong W
    Virology; 2001 Jun; 285(1):6-11. PubMed ID: 11414800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dynamic behavior of hepatitis C virus quasispecies in a long-term culture of the three-dimensional radial-flow bioreactor system.
    Murakami K; Inoue Y; Hmwe SS; Omata K; Hongo T; Ishii K; Yoshizaki S; Aizaki H; Matsuura T; Shoji I; Miyamura T; Suzuki T
    J Virol Methods; 2008 Mar; 148(1-2):174-81. PubMed ID: 18164425
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atypical activation of the RNA sensor MDA5 by hepatitis C virus.
    Chakraborty S; Zhu J; Gack MU
    FEBS J; 2024 Mar; 291(6):1115-1118. PubMed ID: 38102741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.
    Paul D; Hoppe S; Saher G; Krijnse-Locker J; Bartenschlager R
    J Virol; 2013 Oct; 87(19):10612-27. PubMed ID: 23885072
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions.
    Pellerin M; Lopez-Aguirre Y; Penin F; Dhumeaux D; Pawlotsky JM
    J Virol; 2004 May; 78(9):4617-27. PubMed ID: 15078944
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns.
    Sullivan DG; Wilson JJ; Carithers RL; Perkins JD; Gretch DR
    J Virol; 1998 Dec; 72(12):10036-43. PubMed ID: 9811742
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NS5A mutations predict biochemical but not virological response to interferon-alpha treatment of sporadic hepatitis C virus infection in European patients.
    Stratidaki I; Skoulika E; Kelefiotis D; Matrella E; Alexandrakis G; Economou A; Kouroumalis E
    J Viral Hepat; 2001 Jul; 8(4):243-8. PubMed ID: 11454174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients.
    Sede MM; Laufer NL; Quarleri J
    Int J Antimicrob Agents; 2015 Aug; 46(2):219-24. PubMed ID: 26100213
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy.
    Vuillermoz I; Khattab E; Sablon E; Ottevaere I; Durantel D; Vieux C; Trepo C; Zoulim F
    J Med Virol; 2004 Sep; 74(1):41-53. PubMed ID: 15258967
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations.
    Middleton T; He Y; Pilot-Matias T; Tripathi R; Lim BH; Roth A; Chen CM; Koev G; Ng TI; Krishnan P; Pithawalla R; Mondal R; Dekhtyar T; Lu L; Mo H; Kati WM; Molla A
    J Virol Methods; 2007 Nov; 145(2):137-45. PubMed ID: 17604129
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.
    Chukkapalli V; Berger KL; Kelly SM; Thomas M; Deiters A; Randall G
    Virology; 2015 Feb; 476():168-179. PubMed ID: 25546252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic complementation of hepatitis C virus nonstructural protein functions associated with replication exhibits requirements that differ from those for virion assembly.
    Herod MR; Schregel V; Hinds C; Liu M; McLauchlan J; McCormick CJ
    J Virol; 2014 Mar; 88(5):2748-62. PubMed ID: 24352463
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera.
    Tripathi RL; Krishnan P; He Y; Middleton T; Pilot-Matias T; Chen CM; Lau DT; Lemon SM; Mo H; Kati W; Molla A
    Antiviral Res; 2007 Jan; 73(1):40-9. PubMed ID: 16914212
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Application of Deep Mutational Scanning in Hepatitis C Virus.
    Wu NC; Qi H
    Methods Mol Biol; 2019; 1911():183-190. PubMed ID: 30593626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.